Metformin in Gynecologic Cancers: Opening a New Window for Prevention and Treatment?
Metformin is an affordable and well-tolerated drug used in type 2 diabetes. Potential anti-cancer effects of metformin in gynecologic malignancies include inhibition of the PI3K-mTOR pathway, hormone receptor regulation and decrease of fibrosis and inflammation-multiple studies are currently assessing its role in cancer prevention and as a treatment enhancer.